Amino-acid biomarkers have undergone an evolution in the imaging of gliomas. Several agents have shown to be particularly useful, most notably C-11 MET, F-18 FDOPA, FLT and FET, according to a review of amino-acid imaging published July 8 in the Journal of Nuclear Medicine . {read more here}